0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global RNA Stabilizers Market Research Report 2026
Published Date: 2026-01-28
|
Report Code: QYRE-Auto-23J18359
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global RNA Stabilizers Market Research Report 2024
BUY CHAPTERS

Global RNA Stabilizers Market Research Report 2026

Code: QYRE-Auto-23J18359
Report
2026-01-28
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

RNA Stabilizers Market Size

The global RNA Stabilizers market was valued at US$ 170 million in 2025 and is anticipated to reach US$ 267 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

RNA Stabilizers Market

RNA Stabilizers Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on RNA Stabilizers competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
RNA Stabilizers are substances or reagents designed to preserve the integrity and stability of RNA in biological samples. RNA is highly sensitive to degradation due to ubiquitous RNases (enzymes that break down RNA) and environmental factors. RNA stabilizers are used to prevent degradation during sample collection, storage, and processing, ensuring reliable downstream applications like RNA sequencing, RT-PCR, or gene expression analysis.
The North American market for RNA Stabilizers is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for RNA Stabilizers is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of RNA Stabilizers include Merck, Thermo Fisher Scientific, Takara Bio, Zymo Research, NZYtech, Omega Bio-Tek, Vazyme, BioEntist, Genetix Biotech Asia, SRL, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global RNA Stabilizers market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding RNA Stabilizers. The RNA Stabilizers market size, estimates, and forecasts are provided in terms of sales volume (L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global RNA Stabilizers market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist RNA Stabilizers manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of RNA Stabilizers Market Report

Report Metric Details
Report Name RNA Stabilizers Market
Accounted market size in 2025 US$ 170 million
Forecasted market size in 2032 US$ 267 million
CAGR 6.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Solution-Based Stabilizers
  • Spray or Coating-Based Stabilizers
  • Solid Phase Stabilizers
by Application
  • Molecular Biology
  • Genomics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Thermo Fisher Scientific, Takara Bio, Zymo Research, NZYtech, Omega Bio-Tek, Vazyme, BioEntist, Genetix Biotech Asia, SRL, G-Biosciences, New England Biolabs, Dutscher, NCM Biotech, Beyotime, Yeasen, YaJi Biological, Maokangbio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for RNA Stabilizers manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines RNA Stabilizers sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is RNA Stabilizers Market growing?

Ans: The RNA Stabilizers Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the RNA Stabilizers Market size in 2032?

Ans: The RNA Stabilizers Market size in 2032 will be US$ 267 million.

Who are the main players in the RNA Stabilizers Market report?

Ans: The main players in the RNA Stabilizers Market are Merck, Thermo Fisher Scientific, Takara Bio, Zymo Research, NZYtech, Omega Bio-Tek, Vazyme, BioEntist, Genetix Biotech Asia, SRL, G-Biosciences, New England Biolabs, Dutscher, NCM Biotech, Beyotime, Yeasen, YaJi Biological, Maokangbio

What are the Application segmentation covered in the RNA Stabilizers Market report?

Ans: The Applications covered in the RNA Stabilizers Market report are Molecular Biology, Genomics

What are the Type segmentation covered in the RNA Stabilizers Market report?

Ans: The Types covered in the RNA Stabilizers Market report are Solution-Based Stabilizers, Spray or Coating-Based Stabilizers, Solid Phase Stabilizers

1 RNA Stabilizers Market Overview
1.1 Product Definition
1.2 RNA Stabilizers by Type
1.2.1 Global RNA Stabilizers Market Value by Type: 2025 vs 2032
1.2.2 Solution-Based Stabilizers
1.2.3 Spray or Coating-Based Stabilizers
1.2.4 Solid Phase Stabilizers
1.3 RNA Stabilizers by Application
1.3.1 Global RNA Stabilizers Market Value by Application: 2025 vs 2032
1.3.2 Molecular Biology
1.3.3 Genomics
1.4 Global RNA Stabilizers Market Size Estimates and Forecasts
1.4.1 Global RNA Stabilizers Revenue 2021–2032
1.4.2 Global RNA Stabilizers Sales 2021–2032
1.4.3 Global RNA Stabilizers Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 RNA Stabilizers Market Competition by Manufacturers
2.1 Global RNA Stabilizers Sales Market Share by Manufacturers (2021–2026)
2.2 Global RNA Stabilizers Revenue Market Share by Manufacturers (2021–2026)
2.3 Global RNA Stabilizers Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of RNA Stabilizers, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of RNA Stabilizers, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of RNA Stabilizers, Product Types and Applications
2.7 Global Key Manufacturers of RNA Stabilizers, Date of Entry into the Industry
2.8 Global RNA Stabilizers Market Competitive Situation and Trends
2.8.1 Global RNA Stabilizers Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global RNA Stabilizers Players Market Share by Revenue
2.8.3 Global RNA Stabilizers Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global RNA Stabilizers Market Scenario by Region
3.1 Global RNA Stabilizers Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global RNA Stabilizers Sales by Region: 2021–2032
3.2.1 Global RNA Stabilizers Sales by Region: 2021–2026
3.2.2 Global RNA Stabilizers Sales by Region: 2027–2032
3.3 Global RNA Stabilizers Revenue by Region: 2021–2032
3.3.1 Global RNA Stabilizers Revenue by Region: 2021–2026
3.3.2 Global RNA Stabilizers Revenue by Region: 2027–2032
3.4 North America RNA Stabilizers Market Facts & Figures by Country
3.4.1 North America RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America RNA Stabilizers Sales by Country (2021–2032)
3.4.3 North America RNA Stabilizers Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe RNA Stabilizers Market Facts & Figures by Country
3.5.1 Europe RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe RNA Stabilizers Sales by Country (2021–2032)
3.5.3 Europe RNA Stabilizers Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific RNA Stabilizers Market Facts & Figures by Region
3.6.1 Asia Pacific RNA Stabilizers Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific RNA Stabilizers Sales by Region (2021–2032)
3.6.3 Asia Pacific RNA Stabilizers Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America RNA Stabilizers Market Facts & Figures by Country
3.7.1 Latin America RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America RNA Stabilizers Sales by Country (2021–2032)
3.7.3 Latin America RNA Stabilizers Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa RNA Stabilizers Market Facts & Figures by Country
3.8.1 Middle East and Africa RNA Stabilizers Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa RNA Stabilizers Sales by Country (2021–2032)
3.8.3 Middle East and Africa RNA Stabilizers Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global RNA Stabilizers Sales by Type (2021–2032)
4.1.1 Global RNA Stabilizers Sales by Type (2021–2026)
4.1.2 Global RNA Stabilizers Sales by Type (2027–2032)
4.1.3 Global RNA Stabilizers Sales Market Share by Type (2021–2032)
4.2 Global RNA Stabilizers Revenue by Type (2021–2032)
4.2.1 Global RNA Stabilizers Revenue by Type (2021–2026)
4.2.2 Global RNA Stabilizers Revenue by Type (2027–2032)
4.2.3 Global RNA Stabilizers Revenue Market Share by Type (2021–2032)
4.3 Global RNA Stabilizers Price by Type (2021–2032)
5 Segment by Application
5.1 Global RNA Stabilizers Sales by Application (2021–2032)
5.1.1 Global RNA Stabilizers Sales by Application (2021–2026)
5.1.2 Global RNA Stabilizers Sales by Application (2027–2032)
5.1.3 Global RNA Stabilizers Sales Market Share by Application (2021–2032)
5.2 Global RNA Stabilizers Revenue by Application (2021–2032)
5.2.1 Global RNA Stabilizers Revenue by Application (2021–2026)
5.2.2 Global RNA Stabilizers Revenue by Application (2027–2032)
5.2.3 Global RNA Stabilizers Revenue Market Share by Application (2021–2032)
5.3 Global RNA Stabilizers Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck RNA Stabilizers Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Thermo Fisher Scientific RNA Stabilizers Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Takara Bio
6.3.1 Takara Bio Company Information
6.3.2 Takara Bio Description and Business Overview
6.3.3 Takara Bio RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Takara Bio RNA Stabilizers Product Portfolio
6.3.5 Takara Bio Recent Developments/Updates
6.4 Zymo Research
6.4.1 Zymo Research Company Information
6.4.2 Zymo Research Description and Business Overview
6.4.3 Zymo Research RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zymo Research RNA Stabilizers Product Portfolio
6.4.5 Zymo Research Recent Developments/Updates
6.5 NZYtech
6.5.1 NZYtech Company Information
6.5.2 NZYtech Description and Business Overview
6.5.3 NZYtech RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 NZYtech RNA Stabilizers Product Portfolio
6.5.5 NZYtech Recent Developments/Updates
6.6 Omega Bio-Tek
6.6.1 Omega Bio-Tek Company Information
6.6.2 Omega Bio-Tek Description and Business Overview
6.6.3 Omega Bio-Tek RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Omega Bio-Tek RNA Stabilizers Product Portfolio
6.6.5 Omega Bio-Tek Recent Developments/Updates
6.7 Vazyme
6.7.1 Vazyme Company Information
6.7.2 Vazyme Description and Business Overview
6.7.3 Vazyme RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Vazyme RNA Stabilizers Product Portfolio
6.7.5 Vazyme Recent Developments/Updates
6.8 BioEntist
6.8.1 BioEntist Company Information
6.8.2 BioEntist Description and Business Overview
6.8.3 BioEntist RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BioEntist RNA Stabilizers Product Portfolio
6.8.5 BioEntist Recent Developments/Updates
6.9 Genetix Biotech Asia
6.9.1 Genetix Biotech Asia Company Information
6.9.2 Genetix Biotech Asia Description and Business Overview
6.9.3 Genetix Biotech Asia RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Genetix Biotech Asia RNA Stabilizers Product Portfolio
6.9.5 Genetix Biotech Asia Recent Developments/Updates
6.10 SRL
6.10.1 SRL Company Information
6.10.2 SRL Description and Business Overview
6.10.3 SRL RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 SRL RNA Stabilizers Product Portfolio
6.10.5 SRL Recent Developments/Updates
6.11 G-Biosciences
6.11.1 G-Biosciences Company Information
6.11.2 G-Biosciences Description and Business Overview
6.11.3 G-Biosciences RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 G-Biosciences RNA Stabilizers Product Portfolio
6.11.5 G-Biosciences Recent Developments/Updates
6.12 New England Biolabs
6.12.1 New England Biolabs Company Information
6.12.2 New England Biolabs Description and Business Overview
6.12.3 New England Biolabs RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 New England Biolabs RNA Stabilizers Product Portfolio
6.12.5 New England Biolabs Recent Developments/Updates
6.13 Dutscher
6.13.1 Dutscher Company Information
6.13.2 Dutscher Description and Business Overview
6.13.3 Dutscher RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Dutscher RNA Stabilizers Product Portfolio
6.13.5 Dutscher Recent Developments/Updates
6.14 NCM Biotech
6.14.1 NCM Biotech Company Information
6.14.2 NCM Biotech Description and Business Overview
6.14.3 NCM Biotech RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 NCM Biotech RNA Stabilizers Product Portfolio
6.14.5 NCM Biotech Recent Developments/Updates
6.15 Beyotime
6.15.1 Beyotime Company Information
6.15.2 Beyotime Description and Business Overview
6.15.3 Beyotime RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beyotime RNA Stabilizers Product Portfolio
6.15.5 Beyotime Recent Developments/Updates
6.16 Yeasen
6.16.1 Yeasen Company Information
6.16.2 Yeasen Description and Business Overview
6.16.3 Yeasen RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Yeasen RNA Stabilizers Product Portfolio
6.16.5 Yeasen Recent Developments/Updates
6.17 YaJi Biological
6.17.1 YaJi Biological Company Information
6.17.2 YaJi Biological Description and Business Overview
6.17.3 YaJi Biological RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 YaJi Biological RNA Stabilizers Product Portfolio
6.17.5 YaJi Biological Recent Developments/Updates
6.18 Maokangbio
6.18.1 Maokangbio Company Information
6.18.2 Maokangbio Description and Business Overview
6.18.3 Maokangbio RNA Stabilizers Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Maokangbio RNA Stabilizers Product Portfolio
6.18.5 Maokangbio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 RNA Stabilizers Industry Chain Analysis
7.2 RNA Stabilizers Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 RNA Stabilizers Production Mode & Process Analysis
7.4 RNA Stabilizers Sales and Marketing
7.4.1 RNA Stabilizers Sales Channels
7.4.2 RNA Stabilizers Distributors
7.5 RNA Stabilizers Customer Analysis
8 RNA Stabilizers Market Dynamics
8.1 RNA Stabilizers Industry Trends
8.2 RNA Stabilizers Market Drivers
8.3 RNA Stabilizers Market Challenges
8.4 RNA Stabilizers Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global RNA Stabilizers Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global RNA Stabilizers Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global RNA Stabilizers Market Competitive Situation by Manufacturers in 2025
 Table 4. Global RNA Stabilizers Sales (L) of Key Manufacturers (2021–2026)
 Table 5. Global RNA Stabilizers Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global RNA Stabilizers Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global RNA Stabilizers Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market RNA Stabilizers Average Price (US$/mL) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of RNA Stabilizers, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of RNA Stabilizers, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of RNA Stabilizers, Product Types and Applications
 Table 12. Global Key Manufacturers of RNA Stabilizers, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global RNA Stabilizers Companies by Tier (Tier 1, Tier 2, Tier 3), based on RNA Stabilizers Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global RNA Stabilizers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global RNA Stabilizers Sales by Region (L), 2021–2026
 Table 18. Global RNA Stabilizers Sales Market Share by Region (2021–2026)
 Table 19. Global RNA Stabilizers Sales by Region (L), 2027–2032
 Table 20. Global RNA Stabilizers Sales Market Share by Region (2027–2032)
 Table 21. Global RNA Stabilizers Revenue by Region (US$ Million), 2021–2026
 Table 22. Global RNA Stabilizers Revenue Market Share by Region (2021–2026)
 Table 23. Global RNA Stabilizers Revenue by Region (US$ Million), 2027–2032
 Table 24. Global RNA Stabilizers Revenue Market Share by Region (2027–2032)
 Table 25. North America RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America RNA Stabilizers Sales by Country (L), 2021–2026
 Table 27. North America RNA Stabilizers Sales by Country (L), 2027–2032
 Table 28. North America RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
 Table 29. North America RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe RNA Stabilizers Sales by Country (L), 2021–2026
 Table 32. Europe RNA Stabilizers Sales by Country (L), 2027–2032
 Table 33. Europe RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific RNA Stabilizers Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific RNA Stabilizers Sales by Region (L), 2021–2026
 Table 37. Asia Pacific RNA Stabilizers Sales by Region (L), 2027–2032
 Table 38. Asia Pacific RNA Stabilizers Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific RNA Stabilizers Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America RNA Stabilizers Sales by Country (L), 2021–2026
 Table 42. Latin America RNA Stabilizers Sales by Country (L), 2027–2032
 Table 43. Latin America RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa RNA Stabilizers Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa RNA Stabilizers Sales by Country (L), 2021–2026
 Table 47. Middle East and Africa RNA Stabilizers Sales by Country (L), 2027–2032
 Table 48. Middle East and Africa RNA Stabilizers Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa RNA Stabilizers Revenue by Country (US$ Million), 2027–2032
 Table 50. Global RNA Stabilizers Sales (L) by Type (2021–2026)
 Table 51. Global RNA Stabilizers Sales (L) by Type (2027–2032)
 Table 52. Global RNA Stabilizers Sales Market Share by Type (2021–2026)
 Table 53. Global RNA Stabilizers Sales Market Share by Type (2027–2032)
 Table 54. Global RNA Stabilizers Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global RNA Stabilizers Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global RNA Stabilizers Revenue Market Share by Type (2021–2026)
 Table 57. Global RNA Stabilizers Revenue Market Share by Type (2027–2032)
 Table 58. Global RNA Stabilizers Price (US$/mL) by Type (2021–2026)
 Table 59. Global RNA Stabilizers Price (US$/mL) by Type (2027–2032)
 Table 60. Global RNA Stabilizers Sales (L) by Application (2021–2026)
 Table 61. Global RNA Stabilizers Sales (L) by Application (2027–2032)
 Table 62. Global RNA Stabilizers Sales Market Share by Application (2021–2026)
 Table 63. Global RNA Stabilizers Sales Market Share by Application (2027–2032)
 Table 64. Global RNA Stabilizers Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global RNA Stabilizers Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global RNA Stabilizers Revenue Market Share by Application (2021–2026)
 Table 67. Global RNA Stabilizers Revenue Market Share by Application (2027–2032)
 Table 68. Global RNA Stabilizers Price (US$/mL) by Application (2021–2026)
 Table 69. Global RNA Stabilizers Price (US$/mL) by Application (2027–2032)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 73. Merck RNA Stabilizers Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 78. Thermo Fisher Scientific RNA Stabilizers Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. Takara Bio Company Information
 Table 81. Takara Bio Description and Business Overview
 Table 82. Takara Bio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 83. Takara Bio RNA Stabilizers Product
 Table 84. Takara Bio Recent Developments/Updates
 Table 85. Zymo Research Company Information
 Table 86. Zymo Research Description and Business Overview
 Table 87. Zymo Research RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 88. Zymo Research RNA Stabilizers Product
 Table 89. Zymo Research Recent Developments/Updates
 Table 90. NZYtech Company Information
 Table 91. NZYtech Description and Business Overview
 Table 92. NZYtech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 93. NZYtech RNA Stabilizers Product
 Table 94. NZYtech Recent Developments/Updates
 Table 95. Omega Bio-Tek Company Information
 Table 96. Omega Bio-Tek Description and Business Overview
 Table 97. Omega Bio-Tek RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 98. Omega Bio-Tek RNA Stabilizers Product
 Table 99. Omega Bio-Tek Recent Developments/Updates
 Table 100. Vazyme Company Information
 Table 101. Vazyme Description and Business Overview
 Table 102. Vazyme RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 103. Vazyme RNA Stabilizers Product
 Table 104. Vazyme Recent Developments/Updates
 Table 105. BioEntist Company Information
 Table 106. BioEntist Description and Business Overview
 Table 107. BioEntist RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 108. BioEntist RNA Stabilizers Product
 Table 109. BioEntist Recent Developments/Updates
 Table 110. Genetix Biotech Asia Company Information
 Table 111. Genetix Biotech Asia Description and Business Overview
 Table 112. Genetix Biotech Asia RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 113. Genetix Biotech Asia RNA Stabilizers Product
 Table 114. Genetix Biotech Asia Recent Developments/Updates
 Table 115. SRL Company Information
 Table 116. SRL Description and Business Overview
 Table 117. SRL RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 118. SRL RNA Stabilizers Product
 Table 119. SRL Recent Developments/Updates
 Table 120. G-Biosciences Company Information
 Table 121. G-Biosciences Description and Business Overview
 Table 122. G-Biosciences RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 123. G-Biosciences RNA Stabilizers Product
 Table 124. G-Biosciences Recent Developments/Updates
 Table 125. New England Biolabs Company Information
 Table 126. New England Biolabs Description and Business Overview
 Table 127. New England Biolabs RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 128. New England Biolabs RNA Stabilizers Product
 Table 129. New England Biolabs Recent Developments/Updates
 Table 130. Dutscher Company Information
 Table 131. Dutscher Description and Business Overview
 Table 132. Dutscher RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 133. Dutscher RNA Stabilizers Product
 Table 134. Dutscher Recent Developments/Updates
 Table 135. NCM Biotech Company Information
 Table 136. NCM Biotech Description and Business Overview
 Table 137. NCM Biotech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 138. NCM Biotech RNA Stabilizers Product
 Table 139. NCM Biotech Recent Developments/Updates
 Table 140. Beyotime Company Information
 Table 141. Beyotime Description and Business Overview
 Table 142. Beyotime RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 143. Beyotime RNA Stabilizers Product
 Table 144. Beyotime Recent Developments/Updates
 Table 145. Yeasen Company Information
 Table 146. Yeasen Description and Business Overview
 Table 147. Yeasen RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 148. Yeasen RNA Stabilizers Product
 Table 149. Yeasen Recent Developments/Updates
 Table 150. YaJi Biological Company Information
 Table 151. YaJi Biological Description and Business Overview
 Table 152. YaJi Biological RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 153. YaJi Biological RNA Stabilizers Product
 Table 154. YaJi Biological Recent Developments/Updates
 Table 155. Maokangbio Company Information
 Table 156. Maokangbio Description and Business Overview
 Table 157. Maokangbio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 158. Maokangbio RNA Stabilizers Product
 Table 159. Maokangbio Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. RNA Stabilizers Distributors List
 Table 163. RNA Stabilizers Customers List
 Table 164. RNA Stabilizers Market Trends
 Table 165. RNA Stabilizers Market Drivers
 Table 166. RNA Stabilizers Market Challenges
 Table 167. RNA Stabilizers Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of RNA Stabilizers
 Figure 2. Global RNA Stabilizers Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global RNA Stabilizers Market Share by Type: 2025 & 2032
 Figure 4. Solution-Based Stabilizers Product Picture
 Figure 5. Spray or Coating-Based Stabilizers Product Picture
 Figure 6. Solid Phase Stabilizers Product Picture
 Figure 7. Global RNA Stabilizers Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global RNA Stabilizers Market Share by Application: 2025 & 2032
 Figure 9. Molecular Biology
 Figure 10. Genomics
 Figure 11. Global RNA Stabilizers Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global RNA Stabilizers Market Size (US$ Million), 2021–2032
 Figure 13. Global RNA Stabilizers Sales (L), 2021–2032
 Figure 14. Global RNA Stabilizers Average Price (US$/mL), 2021–2032
 Figure 15. RNA Stabilizers Report Years Considered
 Figure 16. RNA Stabilizers Sales Share by Manufacturers in 2025
 Figure 17. Global RNA Stabilizers Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global RNA Stabilizers Players: Market Share by Revenue in RNA Stabilizers in 2025
 Figure 19. RNA Stabilizers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global RNA Stabilizers Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America RNA Stabilizers Sales Market Share by Country (2021–2032)
 Figure 22. North America RNA Stabilizers Revenue Market Share by Country (2021–2032)
 Figure 23. United States RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe RNA Stabilizers Sales Market Share by Country (2021–2032)
 Figure 26. Europe RNA Stabilizers Revenue Market Share by Country (2021–2032)
 Figure 27. Germany RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific RNA Stabilizers Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific RNA Stabilizers Revenue Market Share by Region (2021–2032)
 Figure 34. China RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America RNA Stabilizers Sales Market Share by Country (2021–2032)
 Figure 42. Latin America RNA Stabilizers Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa RNA Stabilizers Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa RNA Stabilizers Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE RNA Stabilizers Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of RNA Stabilizers by Type (2021–2032)
 Figure 53. Global Revenue Market Share of RNA Stabilizers by Type (2021–2032)
 Figure 54. Global RNA Stabilizers Price (US$/mL) by Type (2021–2032)
 Figure 55. Global Sales Market Share of RNA Stabilizers by Application (2021–2032)
 Figure 56. Global Revenue Market Share of RNA Stabilizers by Application (2021–2032)
 Figure 57. Global RNA Stabilizers Price (US$/mL) by Application (2021–2032)
 Figure 58. RNA Stabilizers Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network